BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9466941)

  • 21. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
    Siddiqui JF; Van Mater D; Sowden MP; Smith HC
    Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-->U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC-1 from the American opossum Monodelphus domestica.
    Fujino T; Navaratnam N; Jarmuz A; von Haeseler A; Scott J
    Nucleic Acids Res; 1999 Jul; 27(13):2662-71. PubMed ID: 10373583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
    Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
    Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed.
    Yamanaka S; Poksay KS; Balestra ME; Zeng GQ; Innerarity TL
    J Biol Chem; 1994 Aug; 269(34):21725-34. PubMed ID: 8063816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC-1 dependent cytidine to uridine editing of apolipoprotein B RNA in yeast.
    Dance GS; Sowden MP; Yang Y; Smith HC
    Nucleic Acids Res; 2000 Jan; 28(2):424-9. PubMed ID: 10606639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mehta A; Kinter MT; Sherman NE; Driscoll DM
    Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity.
    Anant S; Martin SA; Yu H; MacGinnitie AJ; Devaney E; Davidson NO
    Mol Biochem Parasitol; 1997 Sep; 88(1-2):105-14. PubMed ID: 9274872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apobec-1 and apolipoprotein B mRNA editing.
    Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
    Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionary analysis of RNA editing enzymes.
    Chang BH; Chan L
    Methods; 1998 May; 15(1):41-50. PubMed ID: 9614651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
    Fossat N; Tam PP
    RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.
    Hersberger M; Innerarity TL
    J Biol Chem; 1998 Apr; 273(16):9435-42. PubMed ID: 9545269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein B: from editosome to proteasome.
    Chan L; Chang BH; Liao W; Oka K; Lau PP
    Recent Prog Horm Res; 2000; 55():93-125; discussion 126. PubMed ID: 11036935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.
    Maris C; Masse J; Chester A; Navaratnam N; Allain FH
    RNA; 2005 Feb; 11(2):173-86. PubMed ID: 15659357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase.
    Navaratnam N; Morrison JR; Bhattacharya S; Patel D; Funahashi T; Giannoni F; Teng BB; Davidson NO; Scott J
    J Biol Chem; 1993 Oct; 268(28):20709-12. PubMed ID: 8407891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein B messenger RNA editing: insights into the molecular regulation of post-transcriptional cytidine deamination.
    Davidson NO; Anant S; MacGinnitie AJ
    Curr Opin Lipidol; 1995 Apr; 6(2):70-4. PubMed ID: 7773570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
    Mehta A; Driscoll DM
    RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
    Krause K; Marcu KB; Greeve J
    Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The APOBEC-2 crystal structure and functional implications for the deaminase AID.
    Prochnow C; Bransteitter R; Klein MG; Goodman MF; Chen XS
    Nature; 2007 Jan; 445(7126):447-51. PubMed ID: 17187054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.